Navigation Links
Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans
Date:8/2/2011

products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient population; that new collaborative partners will be found; that additional product opportunities will be established; or that that third parties on whom we depend will perform as anticipated.

Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission.  We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2011 Cardium Therapeutics, Inc.  All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics®, Generx®, Cardionovo™, Tissue Repair™, Gene Activated Matrix™, GAM™, Excellagen™, Excellarate™, Osteorate™, MedPodium™, Appexium™, Linee™, Alena™, Cerex™ and Nutra-Apps™ are trademarks of Cardium Therapeutics, Inc. or Tissue Repair Company.

(Other trademarks belong to their respective owners)


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015  As the pharmaceutical industry works ... & Compliance professionals are placing a significant emphasis ... issued today by LRN, the leader in Ethics ... majority of respondents expressed that clarity on company ... of E&C training programs (57%), trumping understanding of ...
(Date:3/5/2015)... ANDOVER, Mass. , March 5, 2015   ... pulmonary function testing (PFT) that employs precise ultrasound technology, ... free clinic event held by the San Antonio Pulmonary ... lung disease (ILD) or pulmonary fibrosis (PF), as well ... With a footprint of a mere 12 square ...
(Date:3/5/2015)... 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss year-end 2014 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
Breaking Medicine Technology:Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... Texas, Sept. 10 The first-ever human,clinical trial ... was,recently conducted, testing whether the tea can possibly ... trial also generated the first human safety data ... consumption of rooibos tea is safe for the ...
... - Abstracts 186 and 1003, Sanofi-aventis announced ... presented at the 44th annual meeting of the ... that a basal-bolus insulin,regimen with LANTUS(R) (insulin glargine ... APIDRA(R) (insulin glulisine [rDNA,origin] injection) at mealtime (bolus ...
Cached Medicine Technology:Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 2Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 3Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 4
(Date:3/6/2015)... Parents need to start the discourse with ... disorders. School programs like DARE, or Drug Abuse Resistance ... Narcotics Overdose Prevention and Education has already impacted a ... on Feb. 27th. As teens continue to suffer ... prevention proponents are lobbying Florida to pass The Overdose ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend ... trends and statistics on one of the nation’s biggest ... Rx Management will discuss key findings from the report ... Drug Spend,” a complimentary March 19 webinar, managed and ... spend makes up more than a quarter of total ...
(Date:3/6/2015)... ON (PRWEB) March 06, 2015 ... the Canadian Celiac Association, is pleased to announce ... by Dufflet Rosenberg, has expanded their product line ... they are as scrumptious and as satisfying as ... hand-crafted from scratch, and never contains hydrogenated fats ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Dr. Mark Sowell ... Education in Scottsdale, AZ. Offering programs for advanced education in ... over the world. , As a visiting faculty member ... “teach and learn” each time he visits Spear Education to ... Dr. Sowell remarks, “we are training only the top 10% ...
Breaking Medicine News(10 mins):Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2
... occurring with hay fever, are nine times more likely to ... The study was conducted by the University of ... Monash University. Published online in the ... on evidence from a clinical study of around 1400 grown ...
... Reporter , THURSDAY, April 14 (HealthDay News) -- In the ... for the management of type 1 diabetes, British researchers report ... reduce the risk of dangerous low blood sugars overnight. ... time that plasma glucose levels were in target "increased by ...
... Strains of genital herpes in Africa are far ... at Harvard Medical School report, a striking insight into ... transmission in a region staggered by the HIV/AIDS epidemic. ... model strains of the disease against vaccine candidates. All ...
... tract infections are common in women, costing an estimated ... the United States alone. These infections frequently recur, ... A depletion of vaginal lactobacilli, a type of bacteria, ... that replenishing these bacteria may be beneficial. Researchers conducted ...
... identified a set of plasma biomarkers that could reasonably ... according to findings published in Clinical Cancer Research ... Research. "The rate at which melanoma is increasing ... patients under surveillance," said Harriet Kluger, M.D., associate professor ...
... , THURSDAY, April 14 (HealthDay News) -- Male humpback ... say. Within regional populations of the whales, males all ... song changes over time, with new versions spreading across the ... the study published online April 14 in the journal ...
Cached Medicine News:Health News:Childhood eczema and hay fever leads to adult allergic asthma 2Health News:Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar 2Health News:Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar 3Health News:Genital herpes more virulent in Africa than in US 2Health News:Genital herpes more virulent in Africa than in US 3Health News:Blood test could predict metastasis risk in melanoma 2Health News:Whales Not Just Singing the Same Old Song, Researchers Say 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: